Legal Representation
Attorney
William Bak
USPTO Deadlines
Next Deadline
1365 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-04-04)
Due Date
April 04, 2029
Grace Period Ends
October 04, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
34 eventsDate | Code | Type | Description |
---|---|---|---|
Feb 21, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Aug 14, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
Jul 24, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED |
Jul 24, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
Jul 4, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Apr 4, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Apr 4, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Jan 25, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB |
Jan 17, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jan 17, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jan 4, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Jan 4, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Dec 28, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Dec 13, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Nov 17, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Nov 17, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Nov 17, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Sep 19, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Sep 19, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Sep 19, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Sep 19, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Sep 19, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Jun 13, 2022 | RFNT | P | REFUSAL PROCESSED BY IB |
May 24, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
May 24, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU |
Apr 16, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Apr 15, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
Apr 15, 2022 | RFWR | P | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
Mar 12, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Mar 11, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
Feb 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
Feb 22, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Feb 18, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Feb 17, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Biopharmaceutical preparations for the treatment of cancers; antibodies and antibody derivatives and fragments, namely, human monoclonal antibodies and their derivatives and fragments for medical use; biopharmaceutical preparations for the treatment of cancer of the brain and of soft tissue
Classification
International Classes
005